These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 99517)
1. Diethyl (4baalpha,4calpha,9aalpha,9balpha)-3,6-dichlorocyclobuta[1,2-b:3,4-b']bisbenzofuran-9a,9b(4bH,4cH)-dicarboxylate: the cis,syn photodimer of ethyl 5-chlorobenzofuran-2-carboxylate, an analogue related to the antilipidemic drug clofibrate. Witiak DT; Newman HA; Poochikian GK; Fogt SW; Baldwin JR; Sober CL; Feller DR J Med Chem; 1978 Aug; 21(8):833-7. PubMed ID: 99517 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and pharmacological evaluation of cis-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-1-ones. Tricyclic analogues related to the antilipidemic drug clofibrate. Witiak DT; Loh W; Feller DR; Baldwin JR; Newman HA; Sober CL; Cavestri RC J Med Chem; 1979 Jun; 22(6):699-705. PubMed ID: 110933 [TBL] [Abstract][Full Text] [Related]
3. Antilipidemic activity of 4-oxo-functionalized ethyl 6-chlorochroman-2-carboxylate analogs and a related tricyclic lactone in three rat models. Cavestri RC; Minatelli JA; Baldwin JR; Loh W; Feller DR; Newman HA; Sober CL; Witiak DT Lipids; 1981 Jan; 16(1):30-6. PubMed ID: 7219078 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and antilipidemic properties of cis-7-chloro-3a, 8b-dihydro-3a-methylfuro[3,4-b]benzofuran-3(1H)-one, a tricyclic clofibrate related lactone having a structural resemblance to mevalonolactone. Witiak DT; Kuwano E; Feller DR; Baldwin JR; Newman HA; Sankrappa SK J Med Chem; 1976 Oct; 19(10):1214-20. PubMed ID: 994152 [TBL] [Abstract][Full Text] [Related]
5. Hypolipidemic effects of clofibrate and selected chroman analogs in fasted rats: II. High sucrose-fed animals. Mukhopadhyay A; Patel ST; O'Brien M; Kokrady SS; Newman HA; Witiak DT; Lanese RR; Rice JC; Feller DR Lipids; 1983 Jan; 18(1):59-67. PubMed ID: 6835036 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological evaluation of a clofibrate-related tricyclic spirolactone, 5-chloro-4',5-dihydrospiro[benzofuran-2(3H),3'(2'H)-furan]-2'-one. Witiak DT; Cavestri RC; Newman HA; Baldwin JR; Sober CL; Feller DR J Med Chem; 1978 Dec; 21(12):1198-202. PubMed ID: 722728 [TBL] [Abstract][Full Text] [Related]
7. 9-Chloro-2,3-dihydro-5H-1,4-dioxepino(6,5-b)benzofuran, a novel antilipidemic agent structurally related to clofibrate. Witiak DT; Poochikian GK; Feller DR; Kenfield NA; Newman HA J Med Chem; 1975 Oct; 18(10):992-6. PubMed ID: 1159693 [TBL] [Abstract][Full Text] [Related]
8. Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice. Jiang C; Wang Q; Wei Y; Yao N; Wu Z; Ma Y; Lin Z; Zhao M; Che C; Yao X; Zhang J; Yin Z J Ethnopharmacol; 2015 Dec; 176():17-26. PubMed ID: 26477373 [TBL] [Abstract][Full Text] [Related]
9. Comparative antilipidemic effects of various ethyl 5-substituted benzofuran-, 2,3-dihydrobenzofuran-, and 3(2H)-benzofuranone-2-carboxylate analogs of clofibrate in a triton hyperlipidemic rat model. Witiak DT; Newman HA; Poochikian GK; Loh W; Sankarappa SK Lipids; 1976 May; 11(5):384-91. PubMed ID: 1271976 [TBL] [Abstract][Full Text] [Related]
10. Mode of action of the lipid-lowering agents, clofibrate and BM 15075, on cholesterol biosynthesis in rat liver. Berndt J; Gaumert R; Still J Atherosclerosis; 1978 Jun; 30(2):147-52. PubMed ID: 678316 [TBL] [Abstract][Full Text] [Related]
11. Anticholesterolemic effect of 3,4-di(OH)-phenylpropionic amides in high-cholesterol fed rats. Kim SJ; Bok SH; Lee S; Kim HJ; Lee MK; Park YB; Choi MS Toxicol Appl Pharmacol; 2005 Oct; 208(1):29-36. PubMed ID: 16164959 [TBL] [Abstract][Full Text] [Related]
12. [Anti-hyperlipidemic effect of iodine eggs: studies on the mechanism of its action]. Kaji K; Miyashita M; Seyama Y; Yamashita S Nihon Yakurigaku Zasshi; 1984 May; 83(5):451-7. PubMed ID: 6469134 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological studies of 3-amino-2-methyl-1-phenyl-propanones as hypolipidemic agents in rodents. Huang Y; Hall IH Arch Pharm (Weinheim); 1996 Jul; 329(7):329-38. PubMed ID: 8764881 [TBL] [Abstract][Full Text] [Related]
14. Potential hypolipidemic agents. 7. Synthesis and lipid-lowering properties of 2-(dibenzofuranyloxy)-2-methylpropionates and related compounds. Bondesson G; Hedbom C; Högberg T; Magnusson O; Stjernström NE; Carlson LA J Med Chem; 1974 Jan; 17(1):108-12. PubMed ID: 4808456 [No Abstract] [Full Text] [Related]
15. Investigation of 3,5-isoxazolidinediones as hypolipidemic agents in rodents. Woodard T; Debnath ML; Simlot R; Izydore RA; Daniels DL; Wong OT; ElSourady H; Hall IH Pharm Res; 1995 Jan; 12(1):24-38. PubMed ID: 7724485 [TBL] [Abstract][Full Text] [Related]
17. Comparison of hypocholesterolemic activity for cyclic analogs of clofibrate in normolipemic rats. Goldberg AP; Mellon WS; Witiak DT; Feller DR Atherosclerosis; 1977 May; 27(1):15-25. PubMed ID: 857813 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of benzodioxane, chroman and dihydrobenzofuran analogs of clofibrate in a Triton hyperlipemic rat model. Newman HA; Heilman WP; Witiak DT Lipids; 1973 Jul; 8(7):378-84. PubMed ID: 4724016 [No Abstract] [Full Text] [Related]
19. Dolichol biosynthesis in rat liver peroxisomes. Appelkvist EL Acta Chem Scand B; 1987 Jan; 41(1):73-5. PubMed ID: 3107291 [No Abstract] [Full Text] [Related]
20. Differential effects of benzodioxane, chroman, and dihydrobenzofuran analogs of clofibrate on various parameters of hepatic drug metabolism. Lewis NJ; Feller DR; Poochikian GK; Witiak DT J Med Chem; 1974 Jan; 17(1):41-5. PubMed ID: 4808468 [No Abstract] [Full Text] [Related] [Next] [New Search]